Moldova latest patents query
The latest invention patents collect the data information of Moldova invention patents from 2000 to 2024, typesetting according to the date of patent publication, including patent number, application date, invention Bibliographic data, abstracts, and specification data of people are convenient for scientific researchers to quickly browse and search for patents.
Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy
UndeterminedMDE20250541A1
Owner:IOVANCE BIOTHERAPEUTICS INC
Inhibitors of RNA helicase DHX9 and uses thereof
UndeterminedMDE20250007A1
Owner:ACCENT THERAPEUTICS INC
Fermentation product for the treatment of inflammatory diseases
UndeterminedMDE20250379A1
Owner:ALFASIGMA SPA
Liquid pharmaceutical formulation of omeprazole or esomeprazole
UndeterminedMDE20250094A1
Owner:ALKALOID SKOPJE
Immune modulation and treatment of solid tumors with antibodies that specifically bind CD38
UndeterminedMDE20250367A1
Owner:JANSSEN BIOTECH INC
Methods for treating bullous pemphigoid using FcRN antagonists
UndeterminedMDE20250213A1
Owner:ARGENX BVBA(BE)
Tetrahydrothieno pyridine derivatives as DDRs inhibitors
PendingMDE20250913A1
Owner:CHIESI FARMACEUTICI SPA
Air defense system for Anti-aircraft combat comprizing counter counter measures device to trigger the counter measure of the aircraft prior launching Anti-aircraft missile at the aircraft.
UndeterminedMDE20250293A1
Owner:CARBOTEH TECH D O O
A pharmaceutical formulation for pressurised metered dose inhaler
UndeterminedMDE20250298A1
Owner:CHIESI FARMACEUTICI SPA
Compounds and methods useful for stabilizing phenylalanine hydroxylase mutations
UndeterminedMDE20250045A1
Owner:AGIOS PHARMACEUTICALS INC
Improvements to devices and methods for delivery of substances to animals
PendingMDE20250733A1
Owner:RUMINANT BIOTECH CORP LTD
pH-dependent anti-sulfated glycosaminoglycan antibody and antibody-drug conjugate
UndeterminedMDE20250128A1
Owner:THE UNIV OF TOKYO +1
Combinations of checkpoint inhibitors and oncolytic virus for treating cancer
UndeterminedMDE20250012A1
Owner:REGENERON PHARMACEUTICALS INC +1
Substituted tetrahydrofurans as modulators of sodium channels
PendingMDE20250911A1
Owner:VERTEX PHARMACEUTICALS INC
High purity iron-bearing materials and systems and methods of production thereof
UndeterminedMDE20250220A1
Owner:FORM ENERGY INC
Methods of treating cancer with IAP antagonist compounds and combination therapies
UndeterminedMDE20250051A1
Owner:TAIHO PHARMA CO LTD +1
Pharmaceutical formulation and dosing regimen for the treatment of amyotrophic lateral sclerosis
UndeterminedMDE20250512A1
Owner:AL S PHARMA AG
Anticoagulant therapy with an improved dosage regimen
UndeterminedMDE20250535A1
Owner:ADAMED PHARMA SA
2-Methyl-4',5'-dihydrospiro[piperidine-4,7'-thieno[2,3-c]pyran] derivatives as inhibitors of APOL1 and methods of using same
UndeterminedMDE20241121A1
Owner:VERTEX PHARMACEUTICALS INC
Blood-based screening of subjects for a clinical trial for treatment of tauopathy or amyloidogenic disease
UndeterminedMDE20250344A1
Owner:JANSSEN PHARMA NV
T-type calcium channel modulators comprising an azaspiroheptane core and methods of use thereof
UndeterminedMDE20250152A1
Owner:PRAXIS PRECISION MEDICINES INC
Methods and compositions for genetically modifying a cell
UndeterminedMDE20250350A1
Owner:INTELLIA THERAPEUTICS INC
Cartridge for dynamic reduction of a pressure of a fluid and related device for treating a fluid
UndeterminedMDE20250004A1
Owner:IVAR SPA
Compositions and methods for intrauterine insemination (IUI)
UndeterminedMDE20250381A1
Owner:FERRING BV
Methods for enhancing efficacy of a vaccine by administering an IL-4R antagonist
UndeterminedMDE20250544A1
Owner:REGENERON PHARMACEUTICALS INC
Thermal energy recovery cover panel to produce electricity
UndeterminedMDE20250402A1
Owner:ROBERTO ARPINO +1
Leucine, acetyl leucine, and related analogs for treating disease
PendingMDE20250866A1
Owner:INTRABIO LTD
Heteroaryl compounds for the treatment of pain
UndeterminedMDE20250195A1
Owner:VERTEX PHARMACEUTICALS INC
Ultra-chasmogamous wheat, method for producing ultra-chasmogamous wheat, and method for evaluating ultra-chasmogamous wheat
UndeterminedMDE20250517A1
Owner:KWS SAAT SE & CO KGAA
Gpcr receptor agonists, pharmaceutical compositions comprising the same, and methods for their use
PendingMDE20250862A1
Owner:CARMOT THERAPEUTICS INC
Compositions comprising butyric acid and gluconic acid for the treatment of disorders and syndromes associated with intestinal barrier dysfunctions and dysbiosis
UndeterminedMDE20250050A1
Owner:DIFASS INT
Improved automated production method and manufacturing tooling thereof
UndeterminedMDE20250549A1
Owner:DSIGNTANK SL
Polypeptides useful for gene editing and methods of use
UndeterminedMDE20250295A1
Owner:LIFEEDIT THERAPEUTICS INC
Muscle targeting complexes and uses thereof for treating myotonic dystrophy
UndeterminedMDE20250183A1
Owner:DYNE THERAPEUTICS INC
Phage display-based cell-penetrating peptide discovery platform and methods of making and using the same
UndeterminedMDE20250014A1
Owner:ELI LILLY & CO
Met Bcl-xL inhibitor antibody-drug conjugates and methods of use thereof
UndeterminedMDE20250270A1
Owner:NOVARTIS AG +1
Processes and intermediate for the large-scale preparation of 2,4,6-trifluoro-N-[6-(1-methyl-piperidine-4-carbonyl)-pyridin-2-yl]-benzamide hemisuccinate
UndeterminedMDE20250673A1
Owner:ELI LILLY & CO
Biomarker for treatment of solid cancer by imidazo[4,5-b]pyridine derivative
UndeterminedMDE20250129A1
Owner:CHORDIA THERAPEUTICS INC +1
Dosage regimens for treating multifocal motor neuropathy (MMN)
UndeterminedMDE20250408A1
Owner:ARGENX BVBA(BE)
Means and methods for treating castration-resistant prostate cancer
UndeterminedMDE20250464A1
Owner:MERUS NV
Treatment of hidradenitis suppurativa using JAK inhibitors
UndeterminedMDE20250543A1
Owner:INCYTE CORP
Immersive virtual reality language AI-powered learning method and application
UndeterminedMDE20250114A1
Owner:LE MURA MARIA GRAZIA
Antibodies to ciliary neurotrophic factor receptor (CNTFR) and methods of use thereof
UndeterminedMDE20250411A1
Owner:REGENERON PHARMACEUTICALS INC
Inhibitors of the MYST family of lysine acetyl transferases
UndeterminedMDE20250120A1
Owner:ISOSTERIX INC
Coupling device, valve system and method for operating a valve system
UndeterminedMDE20250164A1
Owner:AKRAPOVIC D D
Construction of battery module and systems interfaces for metal-air batteries
UndeterminedMDE20250520A1
Owner:FORM ENERGY INC
Polo-like kinase 4 (PLK4) inhibitors, pharmaceutical compositions, methods of preparation and uses thereof
UndeterminedMDE20250028A1
Owner:REPARE THERAPEUTICS INC
Spiro piperidine derivatives as inhibitors of APOL1 and methods of using same
UndeterminedMDE20241120A1
Owner:VERTEX PHARMACEUTICALS INC
Compositions and methods for reducing MHC class I in a cell
UndeterminedMDE20250353A1
Owner:INTELLIA THERAPEUTICS INC
Pharmaceutical formulations of a Bruton's tyrosine kinase inhibtor
UndeterminedMDE20250093A1
Owner:PHARMACYCLICS LLC
Multi-layer insulation panel, method for producing a multi-layer insulation panel, and use of a mineral material as the thermal insulation layer
UndeterminedMDE20250115A1
Owner:DIETRICH ISOL AG
Talc powder, agent for improving properties of resin, and resin composition
PendingMDE20250746A1
Owner:HAYASHI KASEI CO LTD
Method for synthesizing 1H-furo[3,2-b]imidazo[4,5-d]pyridine compound
UndeterminedMDE20250163A1
Owner:HANGZHOU HIGHLIGHTLL PHARMACEUTICAL CO LTD
Compositions and methods for localized delivery of cytokines for adoptive cell therapy
UndeterminedMDE20250180A1
Owner:PRESIDENT & FELLOWS OF HARVARD COLLEGE
Amido cyclopropyl derivatives as lpa receptor inhibitors
UndeterminedMDE20250065A1
Owner:CHIESI FARMACEUTICI SPA
System and method for manufacturing and assembling packaged electronic modules
UndeterminedMDE20250262A1
Owner:ELLIPSE WORLD INC
Ammonia decarbonization cooling apparatus and method
UndeterminedMDE20250278A1
Owner:JIANGNAN ENVIRONMENTAL TECHNOLOGY INC
Modulators of nausea and vomiting
UndeterminedMDE20250570A1
Owner:DRUGS MINERALS & GENERICS ITALIA SRL IN FORMA ABBREVIATA D M G ITALIA SRL IT
Subcutaneous administration of onfasprodil and dosing methods for use in the treatment of depression disorders
UndeterminedMDE20250308A1
Owner:NOVARTIS AG
Process for the production of microfibrillated cellulose from high-yield Kraft pulp, microfibrillated cellulose obtainable by said process and Kraft pulp and paper products comprising said microfibrillated cellulose
UndeterminedMDE20250109A1
Owner:RAIZ - INSTITUTO DE INVESTIGAÇÃO DA FLORESTA E PAPEL PT
Methods of inhibiting MASP-2 for the treatment and / or prevention of coronavirus-induced acute respiratory distress syndrome
PendingMDE20250845A1
Owner:OMEROS CORP
Heterocyclic derivatives as Janus kinase inhibitors
UndeterminedMDE20250551A1
Owner:CHIESI FARMACEUTICI SPA
Isolation and diagnostic methods using cell type-specific and / or organ-specific extracellular vesicle (EV) markers
UndeterminedMDE20250282A1
Owner:PRESIDENT & FELLOWS OF HARVARD COLLEGE +1
Co-crystals of 4-[4-[3-chloro-4-[1-(2-pyridyl)-2-hydroxy-ethoxy]pyrazolo[1,5-a]pyridin-6-yl]-5-methyl-triazol-1-yl]piperidine-1-carbonitrile derivatives with gallic acid and nicotine amide
UndeterminedMDE20250556A1
Owner:ELI LILLY & CO
Use of anti-CTLA-4 antibodies for treating adenoid cystic carcinoma
UndeterminedMDE20250568A1
Owner:ONCOC4 INC
Method of treating organ diseases or disorders with ASK1 inhibitors
UndeterminedMDE20250431A1
Owner:SEAL ROCK THERAPEUTICS INC
Evolved cytosine deaminases and methods of editing DNA using same
UndeterminedMDE20250500A1
Owner:THE BROAD INST INC +1
A new vamorolone preparation exhibiting improved solubility
UndeterminedMDE20250239A1
Owner:SANTHERA PHARMACEUTICALS (SCHWEIZ) GMBH
Systems and units for marine infrastructure foundation scour protection
UndeterminedMDE20250515A1
Owner:ECONCRETE TECH LTD
Valbenazine, a VMAT2 inhibitor, as a free base of a tosylate or ditosylate salt, for use in the treatment of chorea associated with Huntington's disease
UndeterminedMDE20250077A1
Owner:NEUROCRINE BIOSCIENCES INC
Monovalent anti-TREM2 binding molecules and methods of use thereof
UndeterminedMDE20250116A1
Owner:DENALI THERAPEUTICS INC
Chemical modification of guide RNAs with locked nucleic acid for RNA guided nuclease-mediated gene editing
UndeterminedMDE20250513A1
Owner:LIFEEDIT THERAPEUTICS INC
Universal non-targeting siRNA compositions and methods of use thereof
UndeterminedMDE20250499A1
Owner:ALNYLAM PHARMACEUTICALS INC
Heterocyclic derivatives as Janus kinase inhibitors
UndeterminedMDE20250550A1
Owner:CHIESI FARMACEUTICI SPA
Method of treating melanocortin-4 receptor pathway-associated disorders
UndeterminedMDE20250221A1
Owner:RHYTHM PHARMACEUTICALS INC
Antagonists of the complement system for use in methods of treating paraproteinemic neuropathies
UndeterminedMDE20250494A1
Owner:ARGENX BVBA(BE)
Cartridge, member constituting cartridge, and image forming apparatus
UndeterminedMDE20250457A1
Owner:CANON KK
Gas phase deposition technique for preparation of pharmaceutical compositions
UndeterminedMDE20250322A1
Owner:NANEXA
Protein-drug conjugates comprising camptothecin analogs and methods of use thereof
UndeterminedMDE20250458A1
Owner:REGENERON PHARMACEUTICALS INC
Device for Anti-aircraft spoofing and jamming and an air defense system comprising said device
UndeterminedMDE20250311A1
Owner:CARBOTEH TECH D O O
Compositions comprising chloranraaniliprole and specific semochemical components
UndeterminedMDE20250080A1
Owner:FMC CORP +1
Exatecan-derived topoisomerase-1 inhibitors pharmaceutical compositions, and uses thereof
UndeterminedMDE20250536A1
Owner:MERCK SHARP & DOHME LLC
Methods of treating or preventing spinal muscular atrophy
UndeterminedMDE20250036A1
Owner:BIOGEN MA INC
Polynucleotides encoding Fanconi anemia, complementation group proteins for the treatment of Fanconi anemia
UndeterminedMDE20250117A1
Owner:MODERNATX INC
Compounds having a T-structure formed by at least four cycles for use in the treatment of cancer and other indications
UndeterminedMDE20241122A1
Owner:THERAS INC +2
Process for production of syngas and fuels from carbon dioxide using oxyfuel combustion
UndeterminedMDE20250201A1
Owner:INFINIUM TECHNOLOGY LLC
Immunotherapy methods for patients whose tumors carry a high passenger gene mutation burden
UndeterminedMDE20250576A1
Owner:REGENERON PHARMACEUTICALS INC
Diarylalkane compounds and compositions for use with skin aging and methods of production thereof
UndeterminedMDE20250174A1
Owner:UNIGEN INC
Antibody-drug conjugates of antineoplastic compounds and methods of use thereof
UndeterminedMDE20250271A1
Owner:NOVARTIS AG +1
Methods of inhibiting MASP-2 for the treatment and / or prevention of coronavirus-induced acute respiratory distress syndrome
PendingMDE20250844A1
Owner:OMEROS CORP
Intranasal epinephrine formulations and methods for the treatment of disease
PendingMDE20250770A1
Owner:AEGIS THERAPEUTICS LLC +1
Installation for applying a lining composition in the form of dry particulate material to form a working lining onto a permanent refractory layer of a tundish and method for forming a working lining
UndeterminedMDE20250296A1
Owner:VESUVIUS GROUP SA
5-(4-fluorophenyl)-2,3-dihydro-1h-imidazo[1,2-a]imidazole derivatives as alk inhibitors for the treatment of fibrosis
UndeterminedMDE20250356A1
Owner:CHIESI FARMACEUTICI SPA
(4-benzo[d]oxazol-2-yl)-6,7-dihydro-1h-imidazo[4,5-c]pyridine-5(4H)-yl)methanone derivatives as mutant pah stabilizers for the treatment of phenylketonuria
UndeterminedMDE20250048A1
Owner:AGIOS PHARMACEUTICALS INC
Specific increase of dopamine synthesis through targeting of the guanylate cyclase 2c receptor in the treatment of parkinson s disease
UndeterminedMDE20250675A1
Owner:THE UNIV OF AMSTERDAM
Dosing of muscle targeting complexes for treating myotonic dystrophy
UndeterminedMDE20250184A1
Owner:DYNE THERAPEUTICS INC
Device and method for controlling ammonia escape of ammonia-based decarbonization system
UndeterminedMDE20250279A1
Owner:JIANGNAN ENVIRONMENTAL TECHNOLOGY INC
Anti-monomethyl auristatin antibodies and antibody fragments
UndeterminedMDE20250523A1
Owner:THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK US
Transferrin receptor antigen-binding domains and uses therefor
UndeterminedMDE20250447A1
Owner:ALECTOR LLC
4',5'-Dihydrospiro[piperidine-4,7'-thieno[2,3-c]pyran] derivatives as inhibitors of APOL1 and methods of using same
UndeterminedMDE20241126A1
Owner:VERTEX PHARMACEUTICALS INC
Crystal of 7H-pyrrolo[2,3-d]pyrimidine-4-amine derivative
UndeterminedMDE20250199A1
Owner:TAIHO PHARMA CO LTD
Dosage regimen of an anti-CDH6 antibody-drug conjugate
UndeterminedMDE20250301A1
Owner:DAIICHI SANKYO CO LTD